SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-15-002009
Filing Date
2015-05-18
Accepted
2015-05-18 17:25:34
Documents
2
Period of Report
2015-03-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vglife_8k.htm 8-K 20368
2 AMENDED LICENSE AGREEMENT vglife_8k-ex1001.htm EX-10.1 21335
  Complete submission text file 0001019687-15-002009.txt   43113
Mailing Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101
Business Address 121 GRAY AVENUE, SUITE 200 SANTA BARBARA CA 93101 805-879-9000
VG Life Sciences Inc. (Filer) CIK: 0001091326 (see all company filings)

IRS No.: 330814123 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26875 | Film No.: 15874254
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1